Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):,S A Adakun,F M Banda,A Bloom,M Bochnowicz,J Chakaya,A Chansa,H Chiguvare,R Chimzizi,C Colvin,J P Dongo,A Durena,C Duri,R Edmund,A D Harries,I Kathure,F N Kavenga,Y Lin,H Luzze,I Mbithi,M Mputu,A Mubanga,D Nair,M Ngwenya,B Okotu,P Owiti,A Owuor,P Thekkur,C Timire,S Turyahabwe,E Tweyongyere,M YaDiul,R Zachariah,K Zimba
DOI: https://doi.org/10.5588/ijtldopen.24.0082
2024-05-01
Abstract:Background: We examined the feasibility of assessing and referring adults successfully completing TB treatment for comorbidities, risk determinants and disability in health facilities in Kenya, Uganda, Zambia and Zimbabwe. Methods: This was a cross-sectional study within national TB programmes. Results: Health workers assessed 1,063 patients (78% of eligible) in a median of 22 min [IQR 16-35] and found it useful and feasible to accomplish in addition to other responsibilities. For comorbidities, 476 (44%) had HIV co-infection, 172 (16%) had high blood pressure (newly detected in 124), 43 (4%) had mental health disorders (newly detected in 33) and 36 (3%) had diabetes mellitus. The most common risk determinants were 'probable alcohol dependence' (15%) and malnutrition (14%). Disability, defined as walking <400 m in 6 min, was found in 151/882 (17%). Overall, 763 (72%) patients had at least one comorbidity, risk determinant and/or disability. At least two-thirds of eligible patients were referred for care, although 80% of those with disability needed referral outside their original health facility. Conclusions: Seven in 10 patients completing TB treatment had at least one comorbidity, risk determinant and/or disability. This emphasises the need for offering early patient-centred care, including pulmonary rehabilitation, to improve quality of life, reduce TB recurrence and increase long-term survival.